Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flare of myasthenia gravis induced by COVID-19 vaccines.
Ishizuchi K, Takizawa T, Sekiguchi K, Motegi H, Oyama M, Nakahara J, Suzuki S. Ishizuchi K, et al. J Neurol Sci. 2022 May 15;436:120225. doi: 10.1016/j.jns.2022.120225. Epub 2022 Mar 9. J Neurol Sci. 2022. PMID: 35290838 Free PMC article. No abstract available.
Immunodeficiency in patients with thymoma-associated myasthenia gravis.
Ishizuchi K, Takizawa T, Ohnuki Y, Sekiguchi K, Motegi H, Oyama M, Nakahara J, Shiina T, Suzuki S. Ishizuchi K, et al. J Neuroimmunol. 2022 Oct 15;371:577950. doi: 10.1016/j.jneuroim.2022.577950. Epub 2022 Aug 12. J Neuroimmunol. 2022. PMID: 35994947
Anemia in female patients with myasthenia gravis.
Sekiguchi K, Ishizuchi K, Takizawa T, Motegi H, Oyama M, Nakahara J, Suzuki S. Sekiguchi K, et al. Among authors: ishizuchi k. PLoS One. 2022 Sep 6;17(9):e0273720. doi: 10.1371/journal.pone.0273720. eCollection 2022. PLoS One. 2022. PMID: 36067203 Free PMC article.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
16 results